• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018 - Product Image Special Offer Sale Banner

Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018

  • Published: March 2014
  • Region: Global
  • 452 Pages
  • Markets and Markets
Special Offer Banner
25%
OFF
Offer ends 31st Aug 2014
The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer Healthcare Ag
  • Beckman Coulter, Inc.
  • Johnson & Johnson
  • MORE

'Point-Of-Care Diagnostic Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018'

The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the POC diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices and the recall of leading glucose monitoring devices are restraining the growth of this market.

In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional READ MORE >

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation
1.6.2 Market Crackdown & Data Triangulation
1.6.3 Market Share Estimation
1.6.4 Key Data Points Taken From Secondary Sources
1.6.5 Key Data Points From Primary Sources
1.6.6 Assumptions

2 Executive Summary

3 Premium Insights
3.1 Product Growth Matrix
3.2 Life Cycle Analysis, By Geography
3.3 Market Chasm Analysis

4 Market Overview
4.1 Introduction
4.2 Evolution
4.3 Market Segmentation
4.3.1 Poc Diagnostics Market By Product
4.3.2 Poc Diagnostics Market By Prescription Mode
4.3.3 Poc Diagnostics Market By End User
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Huge Prevalence Of Infectious Diseases In Developing Countries
4.4.1.2 Increasing Incidences Of Lifestyle Diseases (Cardiac Diseases And Diabetes)
4.4.1.3 Rising Usage Of Home-Based Poc Devices Is Improving Patient Compliance
4.4.1.4 Private Investments And Venture Funding To Support Development Of New Products
4.4.1.5 Growing Government Support To Magnify The Adoption Of Poc Devices
4.4.1.6 Expansion Of Therapeutic Horizon
4.4.1.7 Fostering Approval Of Novel Immunoassay Techniques
4.4.1.8 Technological Advancements
4.4.1.9 Large Number Of Awareness Campaigns/ Conferences In Developing Countries
4.4.1.10 Decreasing Number Of Technicians Available In Central Labs
4.4.2 Restraints
4.4.2.1 Lack Of Alignment With Definitive Central Lab Methods
4.4.2.2 Disadvantages Of Poc Testing Over Central Lab Methods
4.4.2.3 Recall Of Leading Glucose Monitoring Devices
4.4.2.4 Reluctance To Change The Existing Treatment Practices
4.4.3 Opportunities
4.4.3.1 Emerging Markets (India, China, And Brazil)
4.4.3.2 Healthcare Decentralization
4.4.3.3 Miniaturization Of Poc Testing Devices
4.4.4 Challenges
4.4.4.1 Growing Price-Cutting Measures
4.4.4.2 Stringent And Time-Consuming Regulatory Policies
4.4.5 Burning Issues
4.4.5.1 Unfavorable Reimbursement Scenario In Many Countries
4.4.5.2 High Cost Of Poc Devices
4.4.6 Winning Imperatives
4.4.6.1 Strategy Of Geographic Expansion In Emerging Markets
4.4.6.2 Strategy Of Development Of Low-Cost Poc Devices
4.4.6.3 Strategy Of Development Of Multi-Assay Poc Devices

5 Industry Trends
5.1 Introduction
5.2 Value Chain Analysis
5.3 Supply Chain Analysis
5.3.1 Key Influencers
5.4 Industry Trends
5.4.1 Standardization Of Poc Testing Devices
5.4.2 Acquisition Of Small Players
5.4.3 Growing Focus On Microfluidics-Based Poc Devices
5.4.3.1 Microfluidic Technology Based Lab-On-A-Chip Devices Will Bring Laboratory Testing To Patient'S Finger Tips
5.5 Pricing And Cost Analysis
5.6 Porter'S Five Forces Analysis
5.6.1 Threat From New Entrants
5.6.2 Threat From Substitutes
5.6.3 Bargaining Power Of Suppliers
5.6.4 Bargaining Power Of Buyers
5.6.5 Intensity Of Competitive Rivalry
5.7 Pest Analysis
5.7.1 Political Factors
5.7.2 Economic Factors
5.7.3 Social Factors
5.7.4 Technological Factors
5.8 Strategic Benchmarking
5.8.1 Technology Integration & Product Enhancement
5.8.2 Entry Into Tumor/Cancer Testing Market

6 Point-Of-Care Diagnostics Market, By Product
6.1 Introduction
6.2 Glucose Monitoring Kits Market
6.2.1 Glucose Monitoring Strips Market
6.2.2 Glucose Monitoring Devices Market
6.2.3 Lancets Market
6.3 Cardiac Markers Market
6.4 Infectious Dieases Testing Kits Market
6.4.1 Influenza Testing Kits Market
6.4.2 Hiv Testing Kits Market
6.4.3 Hepatitis B Testing Kits Market
6.4.4 Sexually-Transmitted Diseases (Stds) Testing Kits Market
6.4.5 Tuberculosis (Tb) Testing Kits Market
6.4.6 Tropical Diseases Testing Kits Market
6.5 Coagulation Monitoring Kits Market
6.5.1 Prothrombin Time (Pt/Inr) Testing Kits Market
6.5.2 Activated Clotting Time (Act/Aptt) Testing Kits Market
6.6 Pregnancy And Fertility Testing Kits Market
6.6.1 Pregnancy Testing Kits Market
6.6.2 Fertility Testing Kits Market
6.7 Blood Gas/Electrolytes Testing Kits Market
6.8 Tumor/Cancer Markers Market
6.9 Urinalysis Testing Kits Market
6.1 Cholesterol Test Strips Market
6.11 Hematology Testing Kits Market
6.11.1 Hemoglobin Assay Kits Market
6.11.2 Hemostasis Assay Kits Market
6.12 Food Pathogens Testing Kits Market
6.13 Drugs Of Abuse Testing Kits Market
6.14 Fecal Occult Testing Kits Market
6.15 Other Testing Kits Market

7 Point-Of-Care Diagnostics Market, By Prescription Mode
7.1 Introduction
7.2 Prescription-Based Testing Kits Market
7.3 Otc Testing Kits Market

8 Point-Of-Care Diagnostics Market, By End User
8.1 Introduction
8.2 Patient Professional Monitoring Kits Market
8.2.1 Inpatient Monitoring Kits Market
8.2.2 Outpatient Monitoring Kits Market
8.2.3 Special Areas Monitoring Kits Market
8.2.4 Other Areas Professional Monitoring Kits Market
8.3 Patient Self-Monitoring Kits Market

9 Point-Of-Care Diagnostics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest Of Europe (Roe)
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest Of Asia-Pacific
9.5 Rest Of The World (Row)
9.5.1 Latin America
9.5.2 Africa
9.5.3 Middle East

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, Poc Diagnostics Market (Excluding Blood Glucose Monitoring Kits)
10.3 Market Share Analysis, Blood Glucose Monitoring Kits Market
10.4 Competitive Situation And Trends
10.4.1 New Product Launches
10.4.2 Agreements, Partnerships, Collaborations, & Joint Ventures
10.4.3 Mergers And Acquisitions
10.4.4 Expansions
10.4.5 Other Developments

11 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Abaxis, Inc.
11.2 Abbott Laboratories, Inc.
11.3 Alere, Inc.
11.4 Bayer Healthcare Ag (A Subsidiary Of Bayer Ag)
11.5 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation)
11.6 Becton, Dickinson And Company
11.7 Johnson & Johnson
11.8 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation)
11.9 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd)
11.1 Siemens Healthcare (A Division Of Siemens Ag)

*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

Table 1 Global Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 2 Global Glucose Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 3 Glucose Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 4 Glucose Monitoring Strips Market, By Geography, 2011–2018 ($Million)
Table 5 Glucose Monitoring Devices Market, By Geography, 2011–2018 ($Million)
Table 6 Lancets Market, By Geography, 2011–2018 ($Million)
Table 7 Cardiac Markers Market, By Geography, 2011–2018 ($Million)
Table 8 Global Infectious Diseases Testing Kits Market, By Product, 2011–2018 ($Million)
Table 9 Infectious Diseases Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 10 Influenza Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 11 Hiv Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 12 Hepatitis B Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 13 Stds Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 14 Tb Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 15 Tropical Diseases Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 16 Global Coagulation Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 17 Coagulation Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 18 Prothrombin Time (Pt/Inr) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 19 Activated Clotting Time (Act/Aptt) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 20 Global Pregnancy And Fertility Testing Kits Market, By Type, 2011–018 ($Million)
Table 21 Pregnancy And Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 22 Pregnancy Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 23 Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 24 Blood Gas/Electrolytes Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 25 Tumor/Cancer Markers Market, By Geography, 2011–2018 ($Million)
Table 26 Urinalysis Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 27 Cholestrol Test Strips Market, By Geography, 2011–2018 ($Million)
Table 28 Global Hematology Testing Kits Market, By Type, 2011–2018 ($Million)
Table 29 Hematology Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 30 Hemoglobin Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 31 Hemostasis Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 32 Food Pathogens Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 33 Drugs Of Abuse Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 34 Fecal Occult Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 35 Other Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 36 Global Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 37 Prescription-Based Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 38 Otc Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 39 Global Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 40 Patient Professional Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 41 Inpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 42 Outpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 43 Special Areas Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 44 Other Areas Professional Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 45 Patient Self-Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 46 Poc Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 47 North America: Poc Diagnostics Market, By Country, 2011–2018 ($Million)
Table 48 North America: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 49 North America: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 50 North America: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 51 North America: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 52 North America: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 53 North America: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 54 North America: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 55 North America: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 56 North America: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 57 North America: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 58 North America: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 59 North America: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 60 North America: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 61 North America: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 62 North America: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 63 North America: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 64 North America: Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 65 North America: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 66 North America: Poc Diagnostics Market, By End-User, 2011–2018 ($Million)
Table 67 North America: Patient Self–Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 68 North America: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 69 U.S: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 70 U.S.: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 71 U.S.: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 72 Canada: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 73 Canada: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 74 Canada: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 75 Mexico: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 76 Mexico: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 77 Mexico: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 78 Europe: Poc Diagnostics Market, By Country, 2011–2018 ($Million)
Table 79 Europe: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 80 Europe: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 81 Europe: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 82 Europe: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 83 Europe: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 84 Europe: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 85 Europe: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 86 Europe: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 87 Europe: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 88 Europe: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 89 Europe: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 90 Europe: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 91 Europe: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 92 Europe: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 93 Europe: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 94 Europe: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 95 Europe: Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 96 Europe: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 97 Europe: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 98 Europe: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 99 Europe: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 100 Germany: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 101 Germany: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 102 Germany: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 103 France: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 104 France: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 105 France: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 106 U.K.: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 107 U.K.: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 108 U.K.: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 109 Italy: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 110 Italy: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 111 Italy: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 112 Spain: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 113 Spain: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 114 Spain: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 115 Roe: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 116 Roe: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 117 Roe: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 118 Asia-Pacific: Poc Diagnostics Market, By Country, 2011–2018 ($Million)
Table 119 Asia-Pacific: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 120 Asia-Pacific: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 121 Asia-Pacific: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 122 Asia-Pacific: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 123 Asia-Pacific: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 124 Asia-Pacific: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 125 Asia-Pacific: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million)
Table 126 Asia-Pacific: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million)
Table 127 Asia-Pacific: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million)
Table 128 Asia-Pacific: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million)
Table 129 Asia-Pacific: Hematology Testing Kits Market, By Country, 2011–2018 ($Million)
Table 130 Asia-Pacific: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million)
Table 131 Asia-Pacific: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million)
Table 132 Asia-Pacific: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million)
Table 133 Asia-Pacific: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 134 Asia-Pacific: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 135 Asia-Pacific : Otc Testing Kits Market, By Country, 2011–2018 ($Million)
Table 136 Asia-Pacific: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 137 Asia-Pacific: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 138 Asia-Pacific: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 139 Asia-Pacific: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 140 Japan: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 141 Japan: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 142 Japan: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 143 China: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 144 China: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 145 China: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 146 India: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 147 India: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 148 India: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 149 Roa: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 150 Roa: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 151 Roa: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 152 Row: Poc Diagnostics Market, By Region, 2011–2018 ($Million)
Table 153 Row: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 154 Row: Glucose Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 155 Row: Cardiac Markers Market, By Region, 2011–2018 ($Million)
Table 156 Row: Infectious Diseases Testing Kits Market, By Region, 2011–2018 ($Million)
Table 157 Row: Coagulation Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 158 Row: Pregnancy And Fertility Kits Market, By Region, 2011–2018 ($Million)
Table 159 Row: Blood Gas And Electrolytes Testing Kits Market, By Region, 2011–2018 ($Million)
Table 160 Row: Tumor/Cancer Markers Market, By Region, 2011–2018 ($Million)
Table 161 Row: Urinalysis Testing Kits Market, By Region, 2011–2018 ($Million)
Table 162 Row: Cholestrol Test Strips Market, By Region, 2011–2018 ($Million)
Table 163 Row: Hematology Testing Kits Market, By Region, 2011–2018 ($Million)
Table 164 Row: Food Pathogens Testing Kits Market, By Region, 2011–2018 ($Million)
Table 165 Row: Drugs Of Abuse Testing Kits Market, By Region, 2011–2018 ($Million)
Table 166 Row: Fecal Occult Testing Kits Market, By Region, 2011–2018 ($Million)
Table 167 Row: Other Testing Kits Market, By Region, 2011–2018 ($Million)
Table 168 Row: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 169 Row: Otc Testing Kits Market, By Region, 2011–2018 ($Million)
Table 170 Row: Prescription-Based Testing Kits Market, By Region, 2011–2018 ($Million)
Table 171 Row: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 172 Row: Patient Self-Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 173 Row: Professional Monitoring Kits Market, By Region, 2011–2018 ($Million)
Table 174 Latin America: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 175 Latin America: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 176 Latin America: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 177 Africa: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 178 Africa: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 179 Africa: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 180 Middle East: Poc Diagnostics Market, By Product, 2011–2018 ($Million)
Table 181 Middle East: Poc Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 182 Middle East: Poc Diagnostics Market, By End User, 2011–2018 ($Million)
Table 183 New Product Launches, 2011–2014
Table 184 Agreements, Partnerships, Collaborations, And Joint Ventures, 2011–2014
Table 185 Mergers And Acquisitions, 2011–2014
Table 186 Expansions, 2011–2014
Table 187 Other Developments, 2011–2014
Table 188 Abaxis, Inc.: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 189 Abbott Laboratories, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 190 Alere, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 191 Bayer Ag: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 192 Danaher Corporation: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 193 Danaher Corporation: Total Revenue, By Segment, 2010–2012 ($Million)
Table 194 Becton, Dickinson And Company: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 195 Johnson & Johnson: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 196 Nipro Corporation: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 197 Roche Diagnostics Limited: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 198 Siemens Healthcare: Total Revenue And R&D Expenditure, 2011–2013 ($Million)

List Of Figures

Figure 1 Global Poc Diagnostics Market: Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Global Poc Diagnostics Market, By Product, 2013
Figure 4 Global Poc Diagnostics Market, By Geography, 2013
Figure 5 Poc Diagnostics Market: Product Growth Matrix
Figure 6 Poc Diagnostics Market Life Cycle Analysis: By Geography
Figure 7 Poc Diagnostics Market: Chasm Analysis
Figure 8 Evolution Of Poc Testing
Figure 9 Poc Diagnostics Market: By Product
Figure 10 Poc Diagnostics Market: By Prescription Mode
Figure 11 Poc Diagnostics Market: By End User
Figure 12 Market Dynamics: Global Poc Diagnostics Market
Figure 13 Value Chain Analysis: Poc Diagnostics Market
Figure 14 Poc Diagnostics Market: Supply Chain
Figure 15 Pricing Trend: Poc Devices, 2013–2018
Figure 16 Porter'S Five Forces Analysis: Global Poc Diagnostics Market, 2013
Figure 17 Poc Diagnostics Market: Pest Analysis, 2013
Figure 18 Strategic Benchmarking: Technology Integration & Product Enhancement
Figure 19 Strategic Benchmarking: Entry Into Tumor/Cancer Testing Market
Figure 20 Global Poc Diagnostics (Excluding Blood Glucose Monitoring Kits) Market Share, By Key Player, 2012
Figure 21 Global Blood Glucose Monitoring Kits Market Share, By Key Player, 2012
Figure 22 Key Growth Strategies, 2011–2014
Figure 23 Abaxis, Inc.: Total Revenue, By Segment, 2013
Figure 24 Abaxis, Inc.: Total Revenue, By Product And Service Category, 2013
Figure 25 Abaxis, Inc.: Total Revenue, By Geography, 2013
Figure 26 Abbott Laboratories, Inc.: Total Revenue, By Segment, 2012
Figure 27 Abbott Laboratories, Inc.: Total Revenue, By Geography, 2012
Figure 28 Abbott Laboratories, Inc.: Market Strategy, 2011–2013
Figure 29 Alere, Inc.: Total Revenue, By Segments, 2012
Figure 30 Alere, Inc.: Total Revenue, By Geography, 2012
Figure 31 Alere, Inc.: Market Strategy, 2011–2013
Figure 32 Bayer Ag: Total Revenue, By Segment, 2012
Figure 33 Danaher Corporation: Total Revenue, By Segment, 2012
Figure 34 Danaher Corporation: Life Sciences And Diagnostics Segment Revenue Mix, 2012
Figure 35 Danaher Corporation: Life Sciences & Diagnostics Segment Revenue, By Geography, 2012
Figure 36 Beckman Coulter, Inc.: Major Stratgy, 2011–2014
Figure 37 Becton, Dickinson And Company: Total Revenue, By Segment, 2013
Figure 38 Becton, Dickinson And Company: Total Revenue, By Geography, 2013
Figure 39 Becton, Dickinson And Company: Market Strategy, 2011–2014
Figure 40 Johnson & Johnson: Total Revenue, By Segment, 2012
Figure 41 Johnson & Johnson: Total Revenue, By Geography, 2012
Figure 42 Johnson & Johnson: Diagnostics Franchise Revenue, 2010–2012 ($Million)
Figure 43 Johnson & Johnson: Market Strategy, 2011–2013
Figure 44 Nipro Corporation: Total Revenue, By Segment, 2013
Figure 45 Nipro Corporation: Total Revenue, By Geography, 2013
Figure 46 Roche Diagnostics Limited: Total Revenue, By Segment, 2013
Figure 47 Roche Diagnostics Limited: Total Revenue, By Geography, 2013
Figure 48 Roche Diagnostics Limited: Market Strategy, 2011–2013
Figure 49 Siemens Healthcare: Total Revenue, By Geography, 2013
Figure 50 Siemens Healthcare: Market Strategy, 2011–2013

A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of POC testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by the Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of ~13.6% from 2013 to 2018. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as the huge patient population base, increasing funding/investment toward the development of point of care diagnosticproducts, growing focus of both international and domestic players on the Asia-Pacific point-of-care diagnostics market, and large number of R&D activities are driving the growth of the market in the Asia-Pacific region.

New product launches is the key strategy followed by leading market players to ensure their growth in the POC diagnostics market. Moreover, partnerships, agreements, collaboration, and joint ventures; mergers and acquisitions; and expansions are some other growth strategies adopted by industry players in the global market.

The point-of-care diagnostics market is a diversified and competitive market with a large number of players. The market is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.).

- Abaxis, Inc.
- Abbott Laboratories, Inc.
- Alere, Inc.
- Bayer Healthcare Ag
- Beckman Coulter, Inc.
- Becton, Dickinson And Company
- Johnson & Johnson
- Nipro Diagnostics, Inc.
- Roche Diagnostics Limited
- Siemens Healthcare

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos